These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10985927)

  • 1. The metabolism of BW2258U89, a GRP receptor antagonist.
    Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
    Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
    Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
    Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
    Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
    Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
    Moody TW; Staley J; Zia F; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
    Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
    Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells.
    Draoui M; Chung P; Park M; Birrer M; Jakowlew S; Moody TW
    Peptides; 1995; 16(2):289-92. PubMed ID: 7784258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
    Moody TW; Leyton J; Garcia-Marin L; Jensen RT
    Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CI-988 inhibits growth of small cell lung cancer cells.
    Moody TW; Jensen RT
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1154-60. PubMed ID: 11714907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
    Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
    Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Tyr(0),Bpa(4))bombesin is a GRP receptor agonist.
    Casibang M; Moody TW
    Peptides; 2000 May; 21(5):649-53. PubMed ID: 10876047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites.
    Linder KE; Metcalfe E; Arunachalam T; Chen J; Eaton SM; Feng W; Fan H; Raju N; Cagnolini A; Lantry LE; Nunn AD; Swenson RE
    Bioconjug Chem; 2009 Jun; 20(6):1171-8. PubMed ID: 19480415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
    Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29.
    Washington MC; Mhalhal TR; Sayegh AI
    Horm Behav; 2016 Sep; 85():1-4. PubMed ID: 27381650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
    Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
    Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
    Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAI inhibits the growth of small cell lung cancer cells.
    Moody TW; Chiles J; Moody E; Sieczkiewicz GJ; Kohn EC
    Lung Cancer; 2003 Mar; 39(3):279-88. PubMed ID: 12609566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior.
    Bédard T; Mountney C; Kent P; Anisman H; Merali Z
    Behav Brain Res; 2007 Apr; 179(1):133-40. PubMed ID: 17335915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.